TARGETING METTL3 TO OVERCOME DRUG RESISTANCE IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA
$1,565,298FY2025Defense Health AgencyDOD
The University Of Texas Health Science Center At San Antonio
The University Of Texas Health Science Center At San Antonio